TipRanks
YAMASHITA HEALTH CARE HOLDINGS, INC. (JP:9265)
:9265
Japanese Market
Want to see JP:9265 full AI Analyst Report?

YAMASHITA HEALTH CARE HOLDINGS, INC. (9265) AI Stock Analysis

0 Followers

Top Page

JP:9265

YAMASHITA HEALTH CARE HOLDINGS, INC.

(9265)

Select Model
Select Model
Select Model
Neutral 57 (OpenAI - Gpt-5.6Sol)
Rating:57Neutral
Price Target:
¥3,576.00
▲(9.19% Upside)
Action:Reiterated
Date:10/14/26
The score is held back primarily by weak cash generation in 2026 (sharp drop in operating cash flow and negative free cash flow) and bearish/weak near-term technicals (negative MACD and trading below key short-term moving averages). Offsetting factors include a very conservative balance sheet with no debt, strong recent revenue growth, and a reasonable valuation supported by a ~3.1% dividend yield.
Positive Factors
Zero-debt balance sheet
The absence of reported debt materially lowers interest-rate and refinancing exposure, giving the company greater financial resilience. Rising equity also strengthens the balance sheet and provides a more durable foundation for funding operations and absorbing business volatility.
Negative Factors
Weak cash conversion
The sharp deterioration in operating cash flow and the move to negative free cash flow show that reported profitability is converting poorly into cash. Persistently weak conversion could constrain internally funded investment, reduce financial flexibility, and increase reliance on balance-sheet resources.
Read all positive and negative factors
Positive Factors
Negative Factors
Zero-debt balance sheet
The absence of reported debt materially lowers interest-rate and refinancing exposure, giving the company greater financial resilience. Rising equity also strengthens the balance sheet and provides a more durable foundation for funding operations and absorbing business volatility.
Read all positive factors

YAMASHITA HEALTH CARE HOLDINGS, INC. (9265) vs. iShares MSCI Japan ETF (EWJ)

YAMASHITA HEALTH CARE HOLDINGS, INC. Business Overview & Revenue Model

Company Description
Yamashita Health Care Holdings,Inc. engages in the supply of medical equipment in Japan. The company offers diagnostic imaging devices, such as MRI and CT, endoscopic systems, operating tables, and surgical equipment comprising electric scalpels, ...

YAMASHITA HEALTH CARE HOLDINGS, INC. Financial Statement Overview

Summary
Strong revenue growth in 2026 (~+51% YoY) and a conservative, zero-debt balance sheet support stability. However, profitability is thin (EBIT margin ~1.2%, net margin ~1.0%) and cash conversion deteriorated sharply in 2026 (operating cash flow dropped to ~¥0.09B and free cash flow turned about -¥1.20B), which meaningfully increases near-term financial risk.
Income Statement
62
Positive
Balance Sheet
84
Very Positive
Cash Flow
38
Negative
BreakdownMay 2025May 2024May 2023May 2022May 2021
Income Statement
Total Revenue64.15B64.49B61.55B58.20B55.15B
Gross Profit8.55B8.57B8.30B7.86B7.52B
EBITDA1.04B1.06B1.18B1.36B1.15B
Net Income648.00M616.00M580.00M218.00M696.08M
Balance Sheet
Total Assets27.09B27.55B26.56B24.83B24.39B
Cash, Cash Equivalents and Short-Term Investments4.13B5.70B5.30B5.83B3.98B
Total Debt0.000.000.000.000.00
Total Liabilities17.73B18.56B18.00B16.90B16.38B
Stockholders Equity9.36B8.98B8.54B7.91B7.98B
Cash Flow
Free Cash Flow-1.20B338.00M804.00M2.12B473.94M
Operating Cash Flow88.00M617.00M878.00M2.17B581.27M
Investing Cash Flow-1.32B19.00M-1.07B-107.00M-27.66M
Financing Cash Flow-337.00M-240.00M-335.00M-209.00M-230.00M

YAMASHITA HEALTH CARE HOLDINGS, INC. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price3275.00
Price Trends
50DMA
3624.40
Negative
100DMA
3469.14
Positive
200DMA
3436.15
Positive
Market Momentum
MACD
-32.92
Positive
RSI
42.29
Neutral
STOCH
9.52
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9265, the sentiment is Neutral. The current price of 3275 is below the 20-day moving average (MA) of 3532.00, below the 50-day MA of 3624.40, and below the 200-day MA of 3436.15, indicating a neutral trend. The MACD of -32.92 indicates Positive momentum. The RSI at 42.29 is Neutral, neither overbought nor oversold. The STOCH value of 9.52 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:9265.

YAMASHITA HEALTH CARE HOLDINGS, INC. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
¥44.58B11.04―3.44%5.16%37.79%
62
Neutral
¥20.05B10.18―4.19%3.17%-22.27%
57
Neutral
¥8.94B15.88―1.87%-0.41%2.32%
56
Neutral
¥2.51B29.77―3.34%-5.72%-73.78%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
52
Neutral
¥13.45B17.76―3.09%2.87%-73.55%
46
Neutral
¥3.89B11.76―5.43%14.91%-39.00%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:9265
YAMASHITA HEALTH CARE HOLDINGS, INC.
3,500.00
401.33
12.95%
JP:2425
Care Service Co., Ltd.
662.00
-115.66
-14.87%
JP:2689
OLBA HEALTHCARE HOLDINGS, Inc.
1,911.00
-57.41
-2.92%
JP:3417
Ohki Health Care Holdings, Inc.
975.00
-407.61
-29.48%
JP:6062
Charm Care Corporation
1,367.00
317.11
30.20%
JP:7061
Japan Hospice Holdings Inc.
459.00
-817.07
-64.03%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 14, 2026